Gilead has long been at the forefront of HIV research and innovation. We’re excited to announce that our own Moupali Das has received the prestigious AAAS Mani L. Bhaumik Breakthrough …
When Emma received a diagnosis of triple-negative breast cancer, she refused to let it dictate her future. Cancer can take away so much, but at Gilead, we’re striving to reclaim …
Living with primary biliary cholangitis (PBC), a rare and chronic liver condition, can often feel like a lonely journey, says Dilek, a mother of two from Germany who is living …
In 2006, Tomas Cihlar was well aware that, despite initial successes with combination therapy, HIV continued to be a global challenge with limited treatment options. At the time, he had …
To celebrate Women’s History Month, our Identity + Innovation spotlight highlights Devi SenGupta. Discover how her personal journey has influenced her work in advancing new treatments and supporting Gilead’s mission …
In 2015, Lauren Huffmaster was diagnosed with late-stage metastatic breast cancer (mBC) and quickly realized there was limited information to help explain her condition to her young children. “At the …
Cancer can disrupt family life and can have a significant impact on children. “The Adventure Jar,” developed by Gilead in collaboration with the metastatic breast cancer community, offers a glimpse …
For the third consecutive year, Gilead has been honored by Forbes as one of America’s Best Employers for Women. At Gilead, we are committed to fostering a culture where women …
Dr. Summer Sitima, born into a Kenyan family with 24 siblings during the 1990s—a period marked by the HIV epidemic in Sub-Saharan Africa—has a vivid memory from 1997 that deeply …
This year is the fifth anniversary of the Gilead COMPASS Initiative, a 10-year commitment of over $100 million to address the HIV epidemic in the Southern United States. The COMPASS …
Dr. Eva Natukunda, a pediatric HIV specialist at the Joint Clinical Research Center in Kampala, Uganda, often hears from adolescents and young adults living with HIV that they are exhausted. …
When a new COVID-19 virus variant is discovered, Gilead virologists Charlotte Hedskog and John Bilello, along with their teams, mobilize as “variant hunters.” Their mission is to see if COVID-19 …